Related references
Note: Only part of the references are listed.High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine
Judith Straimer et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study
James G. Kublin et al.
CLINICAL INFECTIOUS DISEASES (2021)
Defining the Antimalarial Activity of Cipargamin in Healthy Volunteers Experimentally Infected with Blood-Stage Plasmodium falciparum
James S. McCarthy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
Aline Uwimana et al.
LANCET INFECTIOUS DISEASES (2021)
Evidence of Artemisinin-Resistant Malaria in Africa
Betty Balikagala et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda
Victor Asua et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
Kathrin Witmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway
Gregory M. LaMonte et al.
NATURE COMMUNICATIONS (2020)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
Imidazolopiperazines Kill both Rings and Dormant Rings in Wild-Type and K13 Artemisinin-Resistant Plasmodium falciparum In Vitro
Laurent Dembele et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Cell Swelling Induced by the Antimalarial KAE609 (Cipargamin) and Other PfATP4-Associated Antimalarials
Adelaide S. M. Dennis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Biochemical characterization and chemical inhibition o PfATP4-associated Na+-ATPase activity in Plasmodium falciparum membranes
James E. O. Rosling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
F. Joel Leong et al.
MALARIA JOURNAL (2018)
Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis
Adelaide S. M. Dennis et al.
SCIENTIFIC REPORTS (2018)
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2017)
A Basis for Rapid Clearance of Circulating Ring-Stage Malaria Parasites by the Spiroindolone KAE609
Rou Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions
Michael J. Delves et al.
NATURE PROTOCOLS (2016)
Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance
Gregory LaMonte et al.
MBIO (2016)
Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes
Pamela A. Magistrado et al.
ACS INFECTIOUS DISEASES (2016)
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes
Michelle Yi-Xiu Lim et al.
NATURE MICROBIOLOGY (2016)
Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor
Gregory M. Goldgof et al.
SCIENTIFIC REPORTS (2016)
An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs
Victor Dery et al.
MALARIA JOURNAL (2015)
Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
Erika L. Flannery et al.
ACS CHEMICAL BIOLOGY (2015)
Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
Kesinee Chotivanich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Flow Cytometry-Based Analysis of Artemisinin-Resistant Plasmodium falciparum in the Ring-Stage Survival Assay
Chanaki Amaratunga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Male and Female Gametocyte Functional Viability Assay To Identify Biologically Relevant Malaria Transmission-Blocking Drugs
A. Ruecker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria
Nicholas J. White et al.
MALARIA JOURNAL (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Male and Female Plasmodium falciparum Mature Gametocytes Show Different Responses to Antimalarial Drugs
Michael J. Delves et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
The Spiroindolone Drug Candidate NITD609 Potently Inhibits Gametocytogenesis and Blocks Plasmodium falciparum Transmission to Anopheles Mosquito Vector
J. C. van Pelt-Koops et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
Advait Nagle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
Nicholas J. White et al.
MALARIA JOURNAL (2012)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening
Jacob D. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Share Paper
